‘From Imagination to Impact: A Pioneering Approach to Breakthrough Science’
We are thrilled to welcome Dr. Noubar Afeyan to host a Talks at the Square 13th of March at BII.
Besides being the co-founder of Moderna and board chairman, Noubar Afeyan is the CEO of Flagship Pioneering and has been vital in developing more than 100 scientific ventures resulting in over $100 billion in aggregate value, thousands of patents and patent applications, and more than 50 drugs in clinical development.
During his talk, he will elaborate further on what it takes to assess a good idea and how to execute it to bring it to market for the benefit of people and society.
Program of the day:
15.30 Doors open
16.00 Introduction to BII and the subject of the day: Jens Nielsen, CEO at BII
16.10 Keynote speaker: Dr. Noubar Afeyan ‘From Imagination to Impact: A Pioneering Approach to Breakthrough Science’
16.40 Fireside chat with Jens Nielsen and questions
17.00 Informal networking and closing reception
Please note that the event has free admittance with 60 tickets available. Please sign up quickly to secure your seat.
If you have registered for the event but are unable to attend, please send an email to email@example.com.
About Dr. Noubar Afeyan:
Noubar Afeyan is the founder and CEO of Flagship Pioneering. He is also co-founder and Board Chairman of Moderna. Founded in 2000, Flagship is an enterprise where entrepreneurially-minded scientists invent seemingly unreasonable solutions to challenges facing human health and sustainability. They begin by asking “What if?” and iterate toward the unexpected answers resulting in the creation of first-in-category platform companies with significant impact. Flagship has developed over 100 scientific ventures resulting in over $100 billion in aggregate value, thousands of patents and patent applications, and more than 50 drugs in clinical development.
As an inventor, entrepreneur, and CEO, Noubar has co-founded and helped build over 70 life science and technology startups. He has written numerous scientific publications and inventoried over 100 patents. Noubar’s commitment to improving the human condition through science and business goes hand in hand with social investments and a global humanitarian initiative.